Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists
In spring 2021, a study [5] was published that led to its approval for the treatment of obesity with specific branding and dosing adjustments, see Table 1
It works to help you lose weight by signaling the brain to suppress appetite, improving insulin resistance, and slowing gastric (stomach) emptying, making you feel fuller sooner and for longer periods
Acknowledgements This analysis was funded by Novo Nordisk A/S
US$ 21.70
US$ 25.32
US$ 29.89
US$ 24.97
